Albemarle (ALB) financial statements
+108.5%since 2008
- FY2025 revenue
- $5.1B▼ −4.4%
- FY2025 net income
- −$511M
- FY2025 diluted EPS
- −$5.76
- FY2025 free cash flow
- $692M
Albemarle income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 5,143 | 5,378 | 9,617 |
| Gross profit | 669 | 63 | 1,186 |
| Operating income | -367 | -1,777 | 252 |
| Pretax income | -552 | -1,764 | 247 |
| Net income | -511 | -1,179 | 1,573 |
| Diluted earnings per share | -5.76 | -11.20 | 13.36 |
Albemarle balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 1,618 | 1,192 | 890 |
| Total assets | 16,374 | 16,610 | 18,271 |
| Total liabilities (derived) | 6,593 | 6,410 | 8,606 |
| Total equity | 9,781 | 10,200 | 9,665 |
| Long-term debt | 3,119 | 3,118 | 3,541 |
Albemarle cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 1,282 | 688 | 1,327 |
| Capital expenditure | -590 | -1,681 | -2,155 |
| Free cash flow (derived) | 692 | -993 | -828 |
| Dividends paid | -191 | -189 | -187 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 1,553 | 1,743 | 1,429 | 1,428 |
| Operating income (derived) | 148 | 453 | 234 | -217 |
| Net income (derived) | 297 | 480 | 319 | -414 |
| Diluted earnings per share | 2.15 | 3.52 | 2.34 | n/a |
| Operating cash flow (derived) | 406 | 710 | 346 | 388 |
| Total assets | 16,083 | 15,905 | 15,140 | 16,374 |
Albemarle major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Capital World Investors | 9.5% | 11,279,425 | 14 May 2026 |
| BlackRock, Inc. | 8.1% | 9,694,388 | 17 April 2025 |
| Vanguard Capital Management | 7.4% | 8,679,152 | 29 April 2026 |
| STATE STREET CORPORATION | 5.4% | 6,329,610 | 10 November 2026 |
| Vanguard Portfolio Management | 5.4% | 6,331,772 | 28 April 2026 |
Albemarle 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 4 November 2026 | 10-Q | Quarterly report | Quarterly report |
| 4 November 2026 | 8-K | Current report | Current report |
| 30 October 2026 | 8-K | Current report | Current report |
| 3 September 2026 | 8-K | Current report | Current report |
| 21 August 2026 | 8-K | Current report | Current report |
| 5 August 2026 | 10-Q | Quarterly report | Quarterly report |
| 5 August 2026 | 8-K | Current report | Current report |
| 23 July 2026 | 8-K | Current report | Current report |
Common questions
What was Albemarle's revenue in fiscal 2025?
Albemarle reported $5.1 billion in revenue for fiscal 2025, the year ended 31 December 2025, down 4.4% from fiscal 2024.
What was Albemarle's net income in fiscal 2025?
Albemarle reported a net loss of $511 million for fiscal 2025, the year ended 31 December 2025. Diluted earnings per share were −$5.76.
What was Albemarle's free cash flow in fiscal 2025?
Albemarle had $692 million in free cash flow in fiscal 2025. Operating cash flow was $1.3 billion and capital expenditure was $590 million.
What were Albemarle's total assets at the end of fiscal 2025?
Albemarle reported total assets of $16.4 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much Albemarle history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.